C M Velicer1, S Taplin. 1. Department of Epidemiology, University of Washington, Group Health Cooperative of Puget Sound, Seattle, Washington, USA.
Abstract
PURPOSE: To identify BRCA1/2 knowledge, genetic testing intentions, and communication patterns in breast cancer survivors (survivors). METHODS: A population-based survey was conducted of 276 female survivors diagnosed between the ages of 40 and 49 and living 5 to 10 years postdiagnosis. RESULTS: Of the 79% who responded, 8% spoke with health care providers and 53% spoke with relatives about testing. Few (26%) correctly answered over half the BRCA knowledge questions. Intention to obtain testing varied (26-67%), depending on insurance coverage. CONCLUSION: Health care providers and survivors seldom discuss BRCA testing. Providing information to survivors would increase their ability to make informed testing decisions.
PURPOSE: To identify BRCA1/2 knowledge, genetic testing intentions, and communication patterns in breast cancer survivors (survivors). METHODS: A population-based survey was conducted of 276 female survivors diagnosed between the ages of 40 and 49 and living 5 to 10 years postdiagnosis. RESULTS: Of the 79% who responded, 8% spoke with health care providers and 53% spoke with relatives about testing. Few (26%) correctly answered over half the BRCA knowledge questions. Intention to obtain testing varied (26-67%), depending on insurance coverage. CONCLUSION: Health care providers and survivors seldom discuss BRCA testing. Providing information to survivors would increase their ability to make informed testing decisions.
Entities:
Keywords:
Empirical Approach; Genetics and Reproduction; Professional Patient Relationship
Authors: Julia Hall; Susan Gray; Roger A'Hern; Susan Shanley; Maggie Watson; Kathryn Kash; Robert Croyle; Rosalind Eeles Journal: Fam Cancer Date: 2008-08-05 Impact factor: 2.375
Authors: Anita Yeomans Kinney; Sara Ellis Simonsen; Bonnie Jeanne Baty; Diptasri Mandal; Susan L Neuhausen; Kate Seggar; Rich Holubkov; Ken Smith Journal: Am J Med Genet A Date: 2006-04-15 Impact factor: 2.802
Authors: Tanya N Eble; Sandesh C S Nagamani; Luis M Franco; Sharon E Plon; Maria Blazo; Shweta U Dhar Journal: Am J Med Genet A Date: 2012-12-13 Impact factor: 2.802